These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2920513)

  • 21. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
    Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.
    Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C
    Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
    Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
    Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Some problems concerning the histological diagnosis of gliomas of the brain by CT scan].
    Bai RJ
    Zhonghua Fang She Xue Za Zhi; 1984 Nov; 18(4):244-6. PubMed ID: 6242291
    [No Abstract]   [Full Text] [Related]  

  • 26. [Computed tomographic features of cerebral malignant glioma following treatment and regrowth. Growth patterns of recurrent tumors].
    Sato I; Tanaka R; Takeda N; Suzuki Y; Hondo H
    Neurol Med Chir (Tokyo); 1988 Nov; 28(11):1073-80. PubMed ID: 2466210
    [No Abstract]   [Full Text] [Related]  

  • 27. Programmed serial CT scans in the surgical and radio-chemotherapeutic management of cerebral gliomas.
    Sabattini L; Piazza GC; Finizio FS
    J Neurosurg Sci; 1980; 24(1):33-6. PubMed ID: 7381554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How well do radiologists diagnose intracerebral tumour histology on CT? Findings from a prospective multicentre study.
    Bell D; Grant R; Collie D; Walker M; Whittle IR
    Br J Neurosurg; 2002 Dec; 16(6):573-7. PubMed ID: 12617239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinico-histological study of low-density non-enhancing glioma].
    Maeda T; Nakadai M; Asoh Y; Yokoyama H; Ogashiwa M; Takeuchi K; Akai K
    Neurol Med Chir (Tokyo); 1991 Dec; 31(13):905-11. PubMed ID: 1726251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low grade glioma: a measuring radiographic response to radiotherapy.
    Bauman G; Pahapill P; Macdonald D; Fisher B; Leighton C; Cairncross G
    Can J Neurol Sci; 1999 Feb; 26(1):18-22. PubMed ID: 10068802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calvarial thinning in low grade intracerebral gliomas presenting with epilepsy.
    Jeffree MA; Molyneux AJ; Lee T; Adams C
    Clin Radiol; 1991 Dec; 44(6):406-9. PubMed ID: 1773560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of MRI texture analysis for grading gliomas.
    Ditmer A; Zhang B; Shujaat T; Pavlina A; Luibrand N; Gaskill-Shipley M; Vagal A
    J Neurooncol; 2018 Dec; 140(3):583-589. PubMed ID: 30145731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
    Calcagni ML; Galli G; Giordano A; Taralli S; Anile C; Niesen A; Baum RP
    Clin Nucl Med; 2011 Oct; 36(10):841-7. PubMed ID: 21892031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of FDG and MET Distribution in High- and Low-Grade Gliomas on PET Images.
    Takahashi M; Soma T; Mukasa A; Tanaka S; Yanagisawa S; Momose T
    Clin Nucl Med; 2019 Apr; 44(4):265-271. PubMed ID: 30688731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade Glioma, High Stakes Controversy-When and How to Treat in the Molecular Era?
    Tom MC; Murphy ES
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):516-517. PubMed ID: 29893268
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic Accuracy of Perfusion Computed Tomography in Cerebral Glioma Grading.
    Ahmad N; Shaukat A; Rehan A; Rashid S
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):562-5. PubMed ID: 27504544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
    Pöpperl G; Götz C; Rachinger W; Gildehaus FJ; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1464-70. PubMed ID: 15248032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain tumor target volume determination for radiation treatment planning through automated MRI segmentation.
    Mazzara GP; Velthuizen RP; Pearlman JL; Greenberg HM; Wagner H
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):300-12. PubMed ID: 15093927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic deactivation of low-grade glioma during chemotherapy.
    Roelcke U; Wyss M; Bärtschi E; Hofer S
    J Neurol; 2007 May; 254(5):668-9. PubMed ID: 17410330
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of
    Yi C; Shi X; Zhang X; Luo G; Zhang B; Zhang X
    Ann Nucl Med; 2019 Jan; 33(1):61-67. PubMed ID: 30350180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.